Brielle Urciuoli
CURE Magazine
New Jersey, United States
Contact Brielle
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Brielle:
FDA Grants Adcetris a Breakthrough Therapy Designation for Rare Lymphoma
The Food and Drug Administration (FDA) granted a breakthrough therapy designation to Adcetris (brentuximab vedotin) for the frontline treatment of certain lymphoma subtypes, according to Seattle Genetics, the manufacturer of the antibody-drug conjugate. → Read More
Immunotherapy Provides Long-Awaited Progress in Small Cell Lung Cancer
Promising results from a recent trial are laying the groundwork for the first change in frontline small cell lung cancer in two decades. → Read More
FDA Approves Lorbrena for Metastatic Non-Small Cell Lung Cancer Subtype
The Food and Drug Administration (FDA) granted accelerated approval to Lorbrena (lorlatinib) for the treatment of patients with ALK-positive, metastatic non-small cell lung cancer (NSCLC) who progressed on one or more ALK tyrosine kinase inhibitor (TKI), according to Pfizer, the drug’s manufacturer. → Read More
FDA Approves Keytruda Combination for Non-Small Cell Lung Cancer Subset
The immunotherapy agent received approval for the treatment of metastatic squamous non-small cell lung cancer. → Read More
FDA Approves Talzenna for Breast Cancer Treatment
With this FDA action, Talzenna (talazoparib) is the second PARP inhibitor to be approved in the breast cancer space. → Read More
Late Effects From Brain Tumor Treatment Highlight Need for Survivorship Care
Brain cancer survivors are living longer, highlighting the importance of survivorship care for this population. → Read More
FDA Approves Age Expansion of HPV Vaccine
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine. → Read More
No Sharp Growth Seen in Patients, Survivors of Cancer as Part of Opioid Epidemic
Patients with cancer are 10 times less likely to have an opioid-associated death, according to recent research conducted at Duke University. → Read More
Preventing Myelofibrosis from Progressing to Acute Myeloid Leukemia
Diagnosing and treating the disease before it turns into AML is a key area of study, said Srdan Verstovsek, M.D., Ph.D., medical oncologist and professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. → Read More
Hope Remains for Immunotherapy in Ovarian Cancer
Although immunotherapy’s use in ovarian cancer lags other cancer types, Matthew Powell, M.D., believes there is still promise for checkpoint blockades in this field, likely in combination with other agents. → Read More
FDA Approves Copiktra for Two Types of Blood Cancer
The drug was approved for adults with chronic lymphocytic leukemia and small lymphocytic lymphoma. And was granted an accelerated approval for follicular lymphoma. → Read More
Expert Breaks Down Testing for Genetic Alterations in Metastatic Lung Cancer
With new therapies that can target specific genetic mutations in patients with lung cancer, testing the tumor’s makeup is becoming increasingly important, according to Joshua Bauml, M.D. → Read More
Scanxiety Tips from an Expert
An expert discusses tips on how patients with cancer can manage their "scanxiety." → Read More
FDA Approves New Agent for Hairy Cell Leukemia
The Food and Drug Administration (FDA) approved the use of Lumoxiti (moxetumomab pasudotox-tdfk) for patients with relapsed or refractory hairy cell leukemia (HCL) who previously had at least two prior systemic therapies, including treatment with a purine nucleoside analog. → Read More
John McCain Dies of Glioblastoma at Age 81
Senator and former presidential candidate John McCain died of glioblastoma on Aug. 25. He was 81 years old. → Read More
Overcoming Immune Exhaustion and Improving Lymphoma Outcomes
"One of the big challenges in lymphoma is that many immune cells are present right in the tumor, but somehow those immune cells are not actually killing the tumor cells," explained Stephen M. Ansell, M.D., Ph.D. → Read More
Getting to the Root of Better Gynecologic Cancer Treatment
In recent decades, researchers have gained a much better understanding of how gynecologic cancers develop, especially for women who carry genetic mutations. → Read More
Two Immunotherapies May Address Unmet Need in Mantle Cell Lymphoma
While the treatment landscape of mantle cell lymphoma (MCL) has continued to evolve in recent years, researchers and clinicians alike are still at a loss for curative strategies. But immunotherapy may help. → Read More
Immunotherapy in Bladder Cancer: FDA Updates Labels, Approves Diagnostic Tools
The Food and Drug Administration (FDA) updated the prescribing information for two immunotherapy agents – Keytruda (pembrolizumab) and Tecentriq (atezolizumab) – approved to treat patients with locally advanced or metastatic bladder cancer who are not eligible for cisplatin-based therapy. → Read More
Melanoma Might Not Delay Family Planning
Researchers noted that melanoma diagnosis and treatment did not cause many women to put off becoming pregnant. → Read More